US Stock MarketDetailed Quotes

MTCR Metacrine

Watchlist
  • 0.581400
  • 0.0000000.00%
15min DelayClose Jun 20 16:00 ET
25.48MMarket Cap-570P/E (TTM)

About Metacrine Company

Metacrine Inc is a clinical-stage biopharmaceutical company focused on discovering and developing differentiated therapies for patients with liver and gastrointestinal diseases. Its program targets the farnesoid X receptor, or FXR, which is central to modulating liver and GI diseases. Its FXR product candidates include MET409 and MET642.

Company Profile

SymbolMTCR
Company NameMetacrine
Issue Price13.00
CEOMr. Michael York
MarketPink Market
Employees17
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Websitehttps://www.metacrine.com

Company Executives

  • Name
  • Position
  • Salary
  • Michael York
  • President, Chief Executive Officer, Secretary, Chief Business Officer, Treasurer, Chief Financial Officer and Principal Accounting Officer
  • --
  • Richard Heyman, PhD
  • Chairman of the Board
  • 150.16K
  • Dr. Preston Klassen,M.D.
  • Director
  • 3.67M
  • Dr. Ronald Evans, PhD
  • Independent Director
  • 111.67K
  • Dr. John G. McHutchison, A.O.,M.D.
  • Independent Director
  • 121.67K
  • Julia C. Owens, PhD
  • Independent Director
  • 294.51K
  • Jeffrey David Jonker
  • Independent Director
  • 426.03K
  • Amir H. Nashat, PhD
  • Independent Director
  • 114.66K
  • Andrew L. Guggenhime
  • Independent Director
  • 122.16K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg